FP27 Pituitary: Acromegaly and Prolactinoma

Program: Abstracts - Orals, Featured Poster Presentations, and Posters
Poster Session
Neuroendocrinology and Pituitary-Clinical
Sunday, June 16, 2013: 10:45 AM-11:15 AM
Room 135 (Moscone Center)
Chairs:
Ariel L Barkan, MD and Stephan Petersenn, MD
Philippe J Caron, MD, Dept of Endocrinology & Metabolic Diseases, CHU Larrey, Toulouse, France, John S Bevan, MBChB, MD, FRCP, Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom and Pascal Maisonobe, MSc, Ipsen Pharma, Boulogne-Billancourt, France
Poster Board Number: SUN-90
Marion Dehez, Amandine Manon, Joaquim Ramis and Catherine Lesage, Ipsen, Les Ulis, France
Poster Board Number: SUN-91
Michael C Sheppard, MBCB, PhD, FRCP1, Marcello D Bronstein, MD, PhD2, Pamela U Freda, MD3, Omar Serri, MD, PhD4, Laura De Marinis, MD5, Luciana Ansaneli Naves, MD, PhD6, Liudmila Rozhinskaya, MD7, Karina Hermosillo Reséndiz, MD8, Matthieu Ruffin9, Kobby Asubonteng8 and Annamaria Colao, MD, PhD10, (1)Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, United Kingdom
(2)Neuroendocrine Unit, Division of Endocrinology and Metabolism, University of São Paulo Medical School, São Paulo, Brazil
(3)Department of Medicine, Columbia University College of Physicians & Surgeons, New York, NY
(4)Service of Endocrinology, Centre Hospitalier de l’Université de Montreal, Notre-Dame Hospital, University of Montreal, Montreal, QC, Canada
(5)Section of Endocrinology, Department of Internal Medicine, Università Cattolica del Sacro Cuore, Rome, Italy
(6)Division of Endocrinology, Department of Internal Medicine, University of Brasilia, Brasilia, Brazil
(7)Department of Neuroendocrinology and Bone Diseases, Endocrinology Research Centre, Moscow, Russia
(8)Clinical Development, Novartis Pharmaceuticals Corporation, Florham Park, NJ
(9)Clinical Development, Oncology Business Unit, Novartis Pharma AG, Basel, Switzerland
(10)Dipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy
Poster Board Number: SUN-88
Annamaria Colao, MD, PhD, Dipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy, Marcello D Bronstein, MD, PhD, Neuroendocrine Unit, Division of Endocrinology and Metabolism, University of São Paulo Medical School, São Paulo, Brazil, Feng Gu, MD, Peking Union Medical College Hospital, Beijing, China, Karina Hermosillo Reséndiz, Novartis Pharmaceuticals Corporation, Florham Park, NJ, Matthieu Ruffin, Clinical Development, Oncology Business Unit, Novartis Pharma AG, Basel, Switzerland, YinMiao Chen, Clinical Development, Novartis Pharmaceuticals Corporation, Florham Park, NJ and Pamela U Freda, MD, Department of Medicine, Columbia University College of Physicians & Surgeons, New York, NY
Poster Board Number: SUN-89
Sanne Franck, endocrinology, erasmus university medical center rotterdam, Rotterdan, Netherlands, Aart Jan van der Lely, MD, PhD, Dept of Internal Medicine, Erasmus MC, Rotterdam, Netherlands and Sebastian JCMM Neggers, MD, PhD, Endocrinology, Erasmus MC, Rotterdam, Netherlands
Poster Board Number: SUN-93
Kim M.J.A. Claessen1, Alberto M. Pereira, MD, PhD2, Natasha M. Appelman-Dijkstra, MD1, Neveen Agnes Therese Hamdy, MD, MRCP1, Herman Kroon3, Margreet Kloppenburg4 and Nienke R Biermasz, MD, PhD1, (1)Endocrinology and Metabolism, Center for Endocrine Tumors, Leiden University Medical Center, Netherlands
(2)Endocrinology and Metabolism, Center for Endocrine Tumors Leiden, Leiden University Medical Center, The Netherlands
(3)Radiology, Leiden University Medical Center, Leiden, The Netherlands
(4)Rheumatology, Leiden University Medical Center
Poster Board Number: SUN-92